A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
University of Nebraska
Perspective Therapeutics
Bristol-Myers Squibb
HiFiBiO Therapeutics
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Ipsen
Actym Therapeutics, Inc.
Travera Inc
Azienda Ospedaliera di Padova
University of Pittsburgh
PharmaMar
Columbia University
Instituto do Cancer do Estado de São Paulo